Record Details

Nutraceutical Products of ICAR - CMFRI

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/16498/
CMFRI Pamphlet No. 111/2022
 
Title Nutraceutical Products of ICAR - CMFRI
 
Creator CMFRI, Kochi
 
Subject Algal nutrition
Biochemistry
Seaweed
 
Description There has been a growing interest in marine nutraceuticals in recent years
due to their potential beneficial action for human health. Nutraceutical has also been
defined as 'concentrated, isolated, or purified' pharmacologically bioactive molecules.
Nutraceuticals portray a distinctive intersection of pharmaceutical and food products, and
will continue to have great attraction because they are naturally derived concentrated
pharmacologically active compound(s), and therefore, are intended to function as ‘Natural
Drug'. Nutraceuticals are clearly not drugs, and unlike synthetic drugs, the potential
pharmacologically active substances are derived from natural sources and are concentrated
by using green extraction/purification techniques. The purification process eliminates the
unnecessary components in the product and increases the quantities of the intended
pharmacophore(s), which are specifically active against a particular disease. This apparently
leads to greater pharmacological activities of nutraceutical products. Over the last few years,
The use of marine organisms for the development of nutraceutical products has attracted
interest from the pharmaceutical industries. The rich assemblage of seaweeds and bivalve
mollusk of Asian green mussel Perna Viridis in the Indian marine biosphere represents an
untapped reservoir of bioactive compounds with valuable pharmaceutical and biomedical
use. Seaweeds are often termed the wonder herbs of the ocean due to their potential
pharmaceutical properties. Pioneering research at ICAR-CMFRI developed a hitherto
unraveled database of bioactive molecules and nutraceutical products from the Asian green
mussel Perna viridis and various Indian seaweeds responsible to combat various metabolic
and lifestyle diseases. This subsequently paved the way for the development of
nutraceuticals for use against arthritis, type-2 diabetes, dyslipidemia, hypothyroidism,
non-alcoholic fatty liver disease, osteoporosis, low immunity, and hypertension. The Indian
nutraceutical market has been growing at a compound annual growth rate of 20 percent for
the past three years. With increasing health awareness and the shift towards preventive
health care, India's future in this segment is promising. India's nutraceutical industry is
expected to hold at least 3.5 percent of the global market share by 2023. The nutraceutical
market in India is expected to grow from an estimated $4 billion to $18 billion by the end of
2025. Considering the fact that the global market for nutraceuticals is huge at USD 117
billion, the Indian nutraceutical industry can realize its potential to combat health issues
amidst the Covid-19 wave and can contribute to India's GDP. These developments point
toward the fast proliferation of the specific segments of nutraceuticals in India and their
acceptance by Indian consumers and healthcare providers. The development of
value-added products from Perna viridis and seaweed species also has the potential to
expand the opportunities for their downstream value chain augmentation, thereby boosting
the livelihoods of resource-poor fisher folk and budding entrepreneurs across the coastal
belt. Coupled with a renewed policy focus of the Central government, marine nutraceutical
products are gaining momentum in recent times are poised to create new market
opportunities in India.
 
Publisher ICAR- Central Marine Fisheries Research institute
 
Date 2022
 
Type Other
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/16498/1/Nutraceutical%20Products%20of%20ICAR-CMFRI_2022_Pamphlet.pdf
CMFRI, Kochi (2022) Nutraceutical Products of ICAR - CMFRI. ICAR- Central Marine Fisheries Research institute, Kochi.